OraSure Technologies operates at the intersection of health and technology, providing innovative solutions aimed at improving global health and wellness. The company, along with its subsidiaries DNA Genotek, Diversigen, and Novosanis, delivers a comprehensive suite of products and services, including molecular sampling kits, rapid diagnostic tests for infectious diseases, and stabilization products for molecular applications. Their commitment to empowering individuals to lead healthier lives is reflected in their first-to-market products, such as the OraQuick platform for HIV and Hepatitis C testing. At the core of OraSure’s operations is a mission centered on enhancing access to critical health information, fostering a culture of diversity and inclusion, and maintaining sustainable practices that benefit both employees and the communities they serve.